TOP TIERMARKET NEWSWIRE
News & sentiment

ARMATA PHARMACEUTICA (ARMP) — News & AI sentiment

ARMATA PHARMACEUTICA (ARMP) news roundup. 7 stories in the last 24 hours, 8 in the past week, 10 over 30 days. Average 24-hour sentiment is 69.3/100 — bullish-leaning (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
7
avg sentiment 69.3/100
7d stories
8
avg sentiment 67.5/100
30d stories
10
avg sentiment 65.2/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ARMP news in the last 24 hours, 7 days, 30 days and 90 days

How much ARMP coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowARMP storiesAvg AI sentimentRead
Last 24 hours769.3/100ARMP headlines →
Last 7 days867.5/100ARMP headlines →
Last 30 days1065.2/100ARMP headlines →
Last 90 days2761/100ARMP headlines →

Latest stories on ARMP

15h ago
15h ago
Armata Pharmaceuticals stock rises on FDA breakthrough designation
Investing.com Markets67 · bullishproduct/pr
17h ago
17h ago
17h ago
18h ago
18h ago
5d ago
Sep 3
Sep 3
Aug 12
Aug 12
Aug 12
Jul 20
Jul 20
Jul 20
Jul 17
Jul 13
Jul 13
Jul 13
Jun 24
Jun 23
Jun 23
Jun 23
Jun 23
Open ARMP in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →